PSMA 617
: 2-[3-(1-Carboxy-5-{3-naphthalen-2-yl-2-[(4-{[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraaza-cyclododec-1-yl)-acetylamino]-methyl}-cyclohexanecarbonyl)-amino]-propionylamino}-pentyl)-ureido]-pentanedioic acid, PSMA617 TFA; PSMA617 triflouroacetic acid salt; vipivotide tetraxetan; DKFZ-PSMa-617
: PSMA-617 - a novel theranostic PSMA inhibitor for both diagnosis and endoradiotherapy of prostate cancer.
: PS 0090 (OTTO) PSMA 617 Cas 1702967-37-0 - used in chemical research.
Properties
: Colourless to white to off-white
Safety Information
Safety Information for this product is unavailable at this time.
| Packings | Price (INR) |
|
1 mg
|
390690.00
|
|
5 mg
|
POR
|
|
1 gm
|
POR
|